RE:RE:RE:RE:Load up!With so many shares outstanding, innevitable that this would be played as it is.
As for the good news, maybe it serves as a tool for or validation that the study is moving in the right direction for a take out. Any company contiplating an investment as such would have expected to wait on preliminary results. Most likely, a deal structure that will hing on final results, but done sooner rather than later to realize a downward price.
Tnat was a very good reference for all as to the "anonymous" One of three companies in the world vying for a mainstream pharmac. WILL gain attention, value is there.
GLTA